Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Generated: August 18, 2019

DrugPatentWatch Database Preview

Details for Patent: RE43390

Try a free trial

See Plans and Pricing

« Back to Dashboard

Which drugs does patent RE43390 protect, and when does it expire?

Patent RE43390 protects ALTABAX and is included in one NDA.

This patent has fifty-six patent family members in thirty-five countries.

Summary for Patent: RE43390

Title:	Pleuromutilin derivatives as antimicrobials
Abstract:	The present invention relates to pleuromutilin derivatives, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medical therapy, particularly antibacterial therapy.
Inventor(s):	Berry; Valerie Joan (Chester Springs, PA), Dabbs; Steven (Harlow, GB), Frydrych; Colin Henry (Sawbridgeworth, GB), Hunt; Eric (Great Dunmow, GB), Sanderson; Francis Dominic (Harlow, GB), Woodnutt; Gary (Chester Springs, PA)
Assignee:	GlaxoSmithKline LLC (Philadelphia, PA) SmithKline Beecham Limited (Brentford, Middlesex, GB)
Application Number:	13/102,156
Patent Claim Types: see list of patent claims	Compound; Process; Composition; Use; Dosage form;

Drugs Protected by US Patent RE43390

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Almirall	ALTABAX	retapamulin	OINTMENT;TOPICAL	022055-001	Apr 12, 2007		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y	Y		TREATMENT OF IMPETIGO DUE TO STAPHYLOCOCCUS AUREUS OR STREPTOCOCCUS PYOGENES	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: RE43390

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	9722817	Oct 29, 1997
United Kingdom	9813689	Jun 25, 1998

PCT Information
PCT Filed	October 27, 1998	PCT Application Number:	PCT/GB98/03211
PCT Publication Date:	May 06, 1999	PCT Publication Number:	WO99/21855

International Family Members for US Patent RE43390

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	015987	➤ Sign Up
Austria	277925	➤ Sign Up
Austria	525373	➤ Sign Up
Australia	742167	➤ Sign Up
Australia	9636198	➤ Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.